Provided by Tiger Trade Technology Pte. Ltd.

Anika Therapeutics

12.79
+1.8516.91%
Post-market: 12.890.0953+0.75%16:28 EST
Volume:272.84K
Turnover:3.38M
Market Cap:184.45M
PE:-5.58
High:12.84
Open:11.60
Low:11.60
Close:10.94
52wk High:17.94
52wk Low:7.87
Shares:14.42M
Float Shares:10.36M
Volume Ratio:2.01
T/O Rate:2.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2918
EPS(LYR):-3.8302
ROE:-8.73%
ROA:-3.50%
PB:1.26
PE(LYR):-3.34

Loading ...

Anika FY 2025 GAAP loss from continuing operations hits USD 10.0 million

Reuters
·
Yesterday

Anika Therapeutics Q4 Adj. EPS $0.31 Beats $(0.21) Estimate, Sales $30.615M Beat $28.875M Estimate

Benzinga
·
Yesterday

BRIEF-Anika Therapeutics Q4 Revenue USD 30.615 Million

Reuters
·
Yesterday

Anika Therapeutics Q4 Net Income USD 292 Thousand

THOMSON REUTERS
·
Yesterday

Anika Therapeutics Outlook FY Revenue USD 114-122.5 Million

THOMSON REUTERS
·
Yesterday

Anika Therapeutics Inc: Cingal and Hyalofast Remain Core Strategic Priorities for 2026 as We Prepare for Future U.S. Market Launches

THOMSON REUTERS
·
Yesterday

Anika Therapeutics Inc: Reaffirms 2026 Revenue

THOMSON REUTERS
·
Yesterday

Anika Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire
·
Yesterday

Anika Therapeutics Inc expected to post a loss of 21 cents a share - Earnings Preview

Reuters
·
Feb 24

Anika Therapeutics CEO Steve Griffin to Present at Canaccord Genuity 2026 Musculoskeletal Conference

Reuters
·
Feb 19

Anika Therapeutics Inc. to Announce Fourth Quarter and Year-End Financial Results

Reuters
·
Feb 13

Medacta Group reports 18.5% revenue growth in 2025

Reuters
·
Feb 03

Anika Therapeutics Is Maintained at Outperform by Barrington Research

Dow Jones
·
Jan 09

Anika Therapeutics Announces CEO Transition and Governance Changes

TIPRANKS
·
Jan 09

Anika Therapeutics Names Steve Griffin CEO as Cheryl Blanchard Becomes Executive Chair

Reuters
·
Jan 08

Anika Therapeutics Inc - Cheryl Blanchard to Become Executive Chair of the Board

THOMSON REUTERS
·
Jan 08

Anika Therapeutics Inc - Stephen Griffin Appointed President and CEO

THOMSON REUTERS
·
Jan 08

Anika Therapeutics Announces Leadership Transition

GlobeNewswire
·
Jan 08

Anika Therapeutics Q3 Revenue USD 27.817 Million

Reuters
·
Nov 20, 2025

Anika Therapeutics Is Maintained at Outperform by Barrington Research

Dow Jones
·
Nov 07, 2025